The Effect of Alendronate on Proteome of Hepatocellular Carcinoma Cell Lines
Figure 2
Quantification of the cell progression phases of ALN treated cells at 5 μM for 24, 48, and 72 hrs by FACS. * represents statistically significant value with reference to respective control ().
